|
Puretech Health Plc (NASDAQ: PRTC) |
|
Puretech Health Plc
PRTC's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Puretech Health Plc's sales fell
by -78.68 % in the fourth quarter of 2023 from the same quarter a year ago.
Ranking at No. 367
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -4.85 %
Puretech Health Plc net loss increased from $-37 millions, to $-67 millions in fourth quarter of 2023,
• More on PRTC's Growth
|
|
Puretech Health Plc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 30.54 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1374.44.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.03.
• More on PRTC's Valuation
|
|
|
|
|
Puretech Health Plc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 30.54 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1374.44.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.03.
Puretech Health Plc Price to Book Ratio is at 9.99 lower than Industry Avg. of 32.17. and higher than S&P 500 Avg. of 0.01
• More on PRTC's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com